Literature DB >> 2910913

Biliary copper excretion by hepatocyte lysosomes in the rat. Major excretory pathway in experimental copper overload.

J B Gross1, B M Myers, L J Kost, S M Kuntz, N F LaRusso.   

Abstract

We investigated the hypothesis that lysosomes are the main source of biliary copper in conditions of hepatic copper overload. We used a rat model of oral copper loading and studied the relationship between the biliary output of copper and lysosomal hydrolases. Male Sprague-Dawley rats were given tap water with or without 0.125% copper acetate for up to 36 wk. Copper loading produced a 23-fold increase in the hepatic copper concentration and a 30-65% increase in hepatic lysosomal enzyme activity. Acid phosphatase histochemistry showed that copper-loaded livers contained an increased number of hepatocyte lysosomes; increased copper concentration of these organelles was confirmed directly by both x ray microanalysis and tissue fractionation. The copper-loaded rats showed a 16-fold increase in biliary copper output and a 50-300% increase in biliary lysosomal enzyme output. In the basal state, excretory profiles over time were similar for biliary outputs of lysosomal enzymes and copper in the copper-loaded animals but not in controls. After pharmacologic stimulation of lysosomal exocytosis, biliary outputs of copper and lysosomal hydrolases in the copper-loaded animals remained coupled: injection of colchicine or vinblastine produced an acute rise in the biliary output of both lysosomal enzymes and copper to 150-250% of baseline rates. After these same drugs, control animals showed only the expected increase in lysosomal enzyme output without a corresponding increase in copper output. We conclude that the hepatocyte responds to an increased copper load by sequestering excess copper in an increased number of lysosomes that then empty their contents directly into bile. The results provide direct evidence that exocytosis of lysosomal contents into biliary canaliculi is the major mechanism for biliary copper excretion in hepatic copper overload.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2910913      PMCID: PMC303639          DOI: 10.1172/JCI113873

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  RELATION BETWEEN CIRRHOSIS AND TRACE METAL CONTENT OF LIVER WITH SPECIAL REFERENCE TO PRIMARY BILIARY CIRRHOSIS AND COPPER.

Authors:  A H HUNT; R M PARR; D M TAYLOR; N G TROTT
Journal:  Br Med J       Date:  1963-12-14

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion.

Authors:  R J Coffey; L J Kost; R M Lyons; H L Moses; N F LaRusso
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

Review 4.  A conspectus of research on copper metabolism and requirements of man.

Authors:  K E Mason
Journal:  J Nutr       Date:  1979-11       Impact factor: 4.798

5.  Abnormalities in tests of copper metabolism in primary sclerosing cholangitis.

Authors:  J B Gross; J Ludwig; R H Wiesner; J T McCall; N F LaRusso
Journal:  Gastroenterology       Date:  1985-08       Impact factor: 22.682

6.  Defective biliary excretion of copper in Wilson's disease.

Authors:  D J Frommer
Journal:  Gut       Date:  1974-02       Impact factor: 23.059

7.  Microtubule modulation of biliary excretion of endogenous and exogenous hepatic lysosomal constituents.

Authors:  R B Sewell; S S Barham; A R Zinsmeister; N F LaRusso
Journal:  Am J Physiol       Date:  1984-01

8.  Biliary excretion of iron from hepatocyte lysosomes in the rat. A major excretory pathway in experimental iron overload.

Authors:  G D LeSage; L J Kost; S S Barham; N F LaRusso
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

9.  Triton WR-1339, a lysosomotropic compound, is excreted into bile and alters the biliary excretion of lysosomal enzymes and lipids.

Authors:  N F LaRusso; L J Kost; J A Carter; S S Barham
Journal:  Hepatology       Date:  1982 Mar-Apr       Impact factor: 17.425

10.  Apolipoproteins of high, low, and very low density lipoproteins in human bile.

Authors:  R B Sewell; S J Mao; T Kawamoto; N F LaRusso
Journal:  J Lipid Res       Date:  1983-04       Impact factor: 5.922

View more
  21 in total

1.  Patients, cells, and organelles: the intersection of science and serendipity.

Authors:  Nicholas F Larusso
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

2.  Mechanism of polarized lysosome exocytosis in epithelial cells.

Authors:  Jin Xu; Kimberly A Toops; Fernando Diaz; Jose Maria Carvajal-Gonzalez; Diego Gravotta; Francesca Mazzoni; Ryan Schreiner; Enrique Rodriguez-Boulan; Aparna Lakkaraju
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

3.  Metallothionein-1 and metallothionein-2 gene expression and localisation of apoptotic cells in Zn-treated LEC rat liver.

Authors:  Alessandro Santon; Giacomo Carlo Sturniolo; Vincenzo Albergoni; Paola Irato
Journal:  Histochem Cell Biol       Date:  2003-04-08       Impact factor: 4.304

Review 4.  Aetiology and pathophysiology of chronic liver disorders.

Authors:  J Schölmerich; A Holstege
Journal:  Drugs       Date:  1990       Impact factor: 9.546

5.  The Wilson disease protein ATP7B resides in the late endosomes with Rab7 and the Niemann-Pick C1 protein.

Authors:  Masaru Harada; Takumi Kawaguchi; Hiroto Kumemura; Kunihiko Terada; Haruaki Ninomiya; Eitaro Taniguchi; Shinichiro Hanada; Shinji Baba; Michiko Maeyama; Hironori Koga; Takato Ueno; Koh Furuta; Tatsuo Suganuma; Toshihiro Sugiyama; Michio Sata
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

6.  Effects of copper aspirinate and aspirin on tissue copper, zinc, and iron concentrations following chronic oral treatment in the adjuvant arthritic rat.

Authors:  V Kishore
Journal:  Biol Trace Elem Res       Date:  1990-05       Impact factor: 3.738

Review 7.  Clinical pharmacokinetics of the phosphate binder lanthanum carbonate.

Authors:  Stephen J P Damment; Michael Pennick
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

8.  Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant?

Authors:  J R Forbes; D W Cox
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

9.  Adenosine triphosphate-dependent copper transport in isolated rat liver plasma membranes.

Authors:  M Dijkstra; G In 't Veld; G J van den Berg; M Müller; F Kuipers; R J Vonk
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

10.  Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.

Authors:  E A Wallnöfer; G C Thurner; C Kremser; H Talasz; M M Stollenwerk; A Helbok; N Klammsteiner; K Albrecht-Schgoer; H Dietrich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2020-10-11       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.